About AfriPharma Health Systems
Building pharmaceutical sovereignty in Africa through WHO-aligned manufacturing and supply resilience
The Challenge
Africa imports 88% of its pharmaceuticals, creating supply chain vulnerabilities, higher costs (20-30% premium over local production), limited access to essential medicines, and economic dependency. The COVID-19 pandemic exposed these critical gaps, highlighting the urgent need for local pharmaceutical manufacturing capacity.
Our Solution
AfriPharma Health Systems is establishing a WHO Prequalification-aligned pharmaceutical manufacturing facility in Southern Africa to manufacture 7 WHO Essential Medicines in sterile injectable formats.
WHO GMP Compliance
State-of-the-art facility designed to WHO Good Manufacturing Practice standards from inception, ensuring international quality standards.
21.6M Vials Capacity
Annual production capacity to serve healthcare systems across 15 SADC countries with consistent supply.
Strategic Location
Strategically positioned in Southern Africa with access to efficient regional distribution networks.
Our Vision
To become Africa's leading pharmaceutical manufacturer, contributing to pharmaceutical sovereignty across the continent, healthcare access for underserved populations, economic development through industrialization, skills development in pharmaceutical manufacturing, and regional trade and SADC integration.
Why Southern Africa
- Strategic gateway to 380M people in SADC
- Access to ports and infrastructure for regional distribution
- Special Economic Zone opportunities and investment incentives
- Government commitment to pharmaceutical manufacturing across the region
- Growing regional pharmaceutical market ($3.2B annually, 8-12% CAGR)
Our Commitment
AfriPharma is committed to WHO quality standards, Good Manufacturing Practices (GMP), environmental sustainability, job creation and skills development, and an impact-driven business model that balances financial returns with measurable social outcomes.
Corporate Governance
AfriPharma Health Systems Ltd operates under Mauritius corporate governance framework, ensuring transparency, accountability, and investor protection aligned with international best practices. The company is being formalized under the Mauritius Financial Services Commission (FSC) as a Global Business Company (GBC).